Dr. Shervin Karimpour, MD

Dr. Karimpour practices at Northwestern Medical Group in Chicago, Illinois.

Dr. Karimpour's NPI, 1861469132, was assigned on March 4, 2006. Dr. Karimpour graduated from Rush Medical College in 1996. Dr. Karimpour holds Illinois license 036103808.

Dr. Karimpour's primary practice is Northwestern Medical Group, at 675 N Saint Clair St Ste 19-100 Suite 19-100, Chicago, IL 60611. The practice phone is (312) 664-3278.

Dr. Karimpour's primary practice is Northwestern Medical Group in Chicago, Illinois. Dr. Karimpour is also affiliated with Northwestern Medicine Central DuPage Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Karimpour to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karimpour practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Karimpour's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Karimpour is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Karimpour's licenses on file in 5 states: Illinois, Florida, Maryland, Missouri and Indiana.

Dmand AI lists bone cancer radiation, brain cancer radiation, breast cancer radiation, cervical cancer radiation, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation and lymphoma radiation among the conditions Dr. Karimpour treats.

CMS data shows 3,945 Medicare services from Dr. Karimpour across 22 procedure codes in 2024, for 248 Medicare patients. Medicare paid $549,857 for them.

CMS counts 248 Medicare patients who saw Dr. Karimpour in 2024. The largest group is 65 to 74, with 122 patients. 75% of them have cancer, and 75% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Karimpour's median patient age at 72, with 53% women.

In 2024, Dr. Karimpour wrote 91 Medicare Part D claims for 52 patients. 93% of them were for generic drugs. CMS names the drug for 52 of them, across 2 drugs with 11 or more claims each, at $706 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

Dr. Karimpour accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Karimpour as offering telehealth.

Dmand AI links 7 papers to Dr. Karimpour, published from 2007 to 2024. The most frequent topics are Radiotherapy Dosage. Dr. Karimpour has published most often in Int J Radiat Oncol Biol Phys. Dr. Karimpour's most frequent co-authors are Michael F. Bassetti, Laila Alia Gharzai, MD and David Roy Gius.

CMS Open Payments shows 75 general payments to Dr. Karimpour from 27 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $270.

Dr. Karimpour graduated from Rush Medical College in 1996.

Dr. Karimpour is in network with 15 carriers, including Aetna, Elevance and HCSC. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.